Mr. Barry Balfe
CEO, ICON Pharma Development Solutions
Keynote title
From Development Strategy to Global Clinical Execution: Building Effective Pharma Partnerships
International conference • Academic & industry participation • Limited to 120 participants
|
Dates: 20–22 January 2027
|
Venue: Hilton Singapore Orchard, Singapore
International Conference • Translational Medicine • Biotech Innovation • Clinical Strategy
11th Executive Congress on Translational Medicine Biotech Innovation & Clinical Strategy
ECTMBICS 2027 brings together researchers, clinicians, healthcare professionals, biotechnology innovators, pharmaceutical scientists, industry specialists, academics, and emerging researchers to exchange knowledge and accelerate the journey from scientific discovery to real-world clinical impact.
Focus Areas: Clinical Translation • Biotech Innovation • Pharma Strategy • Digital Health • Clinical Commercialisation
Venue
Hilton Singapore Orchard
Official conference venue
Dates
20–22 January 2027
3-day scientific and professional programme.
Format
Limited to 120 participants
A focused international format with keynote, oral, poster, industry, and networking sessions.
Outcome
Research exchange & collaboration
Designed to support scientific exchange, clinical translation, professional networking, and industry collaboration.
Congress overview
A focused international scientific meeting bringing together keynote lectures, oral and poster presentations, industry exchange, professional networking, collaboration, and publication opportunities.
Dates
20–22 January 2027
Venue
Hilton Singapore Orchard
Participation model
Abstract → Acceptance → Registration
Delegates may register without submitting an abstract
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
International Conference Experience
Clinical Translation • Biotech Strategy • Healthcare Innovation
Key dates
Key milestones for abstract submission, registration, and conference participation.
Abstract submission
31 October 2026
Notification
Within 7–10 days of submission
Early Registration
20 November 2026
Congress dates
20–22 January 2027
Official venue: Hilton Singapore Orchard.
Why participate in ECTMBICS 2027?
A focused international conference connecting research, clinical practice, biotechnology, pharmaceutical innovation, digital health, healthcare strategy, and industry collaboration in a limited-capacity environment.
Focused 120-participant format
Participation is limited to 120 attendees to support quality discussion, meaningful networking, and stronger interaction with speakers.
Limited-capacity international meeting
Scientific & clinical exchange
Keynotes, oral presentations, poster discussions, and focused sessions covering translation, trials, regulation, and healthcare implementation.
Research and professional sessions
Industry–academia collaboration
Connections across universities, hospitals, biotech companies, pharma groups, investors, and innovation hubs.
International networking
Premium support
Invoices, documentation support, delegate assistance, visa-letter guidance, and participation coordination.
Featured Speakers
Featured keynote speakers contributing scientific, clinical, translational, and industry perspectives across biotechnology, pharmaceutical development, precision medicine, digital health, and healthcare innovation.
Prof. Han-Chung Wu
Biomedical Translation Research Center (BioTReC), Taiwan
Keynote title
Advancing Biomedical Translation from Discovery Platforms to Clinical Applications
Matthew Hewitt
Charles River Laboratories
Keynote title
Preclinical Models and Translational Pathways for Next-Generation Therapeutics
Prof. Lani Wu
University of California, San Francisco
Keynote title
Systems-Level Approaches to Translational Medicine and Biomedical Discovery
Dr. Feng-Chi Chen
Institute of Population Health Sciences, National Health Research Institutes
Keynote title
Population Health Evidence and Implementation Pathways for Clinical Translation
Marc Goemans
Chief Commercial Officer, Bora Biologics
Keynote title
Biologics Manufacturing, Commercial Strategy and Global Partnership Models
Dr. Guillermo Del Angel
Center for Genomics Research, AstraZeneca
Keynote title
Genomics-Driven Precision Medicine: Translating Data into Therapeutic Insight
Ed Deng
Co-Founder and CEO, Health2Sync
Keynote title
Digital Health Platforms for Patient Engagement, Monitoring and Clinical Outcomes
Sanghoon Park
CEO, Illimis Therapeutics, Korea
Keynote title
Therapeutics Innovation and Biotech Leadership in Emerging Clinical Pipelines
Conference Partners & Sponsors
ECTMBICS 2027 welcomes organisations supporting translational medicine, biotechnology, clinical research, digital health, diagnostics, healthcare innovation, scientific exchange, and industry collaboration.
Armastec
Advanced medical technology and healthcare innovation support for clinical and translational ecosystems.
CancerfreeBio
Precision oncology and translational biotech innovation focused on cancer research and diagnostics.
Gyder
Digital innovation and intelligent systems supporting healthcare, biotech, and research-driven collaboration.
Intermag
Applied technology and innovation partner supporting cross-sector scientific and industry engagement.
Nanotis
Nanotechnology-enabled diagnostics and biomedical innovation aligned with next-generation healthcare.
Qritive
AI-powered pathology and digital diagnostics platform supporting faster clinical decision-making.
VinBrain
AI healthcare and medical imaging innovation advancing clinical intelligence and digital health systems.
Partner with ECTMBICS 2027
Join the international clinical and biotech innovation community.
Become a Conference Partner
Connect with researchers, clinicians, biotech and pharma professionals, digital health innovators, and conference delegates.
Explore →Themes & focus areas
Conference themes help authors and delegates identify relevant scientific, clinical, and industry tracks.
Translational Medicine & Bench-to-Bedside Innovation
Accelerating discovery from laboratory research to clinical application and patient benefit.
Clinical Trials, Regulatory Science & Approvals
Trial design, regulatory pathways, ethics, evidence generation, and approval strategy.
Biotech Innovation & Therapeutics Development
Biologic therapies, advanced therapeutics, biotech platforms, and development pipelines.
Precision Medicine & Genomics
Genomics, biomarkers, companion diagnostics, stratified treatment, and personalised care.
Digital Health, AI & Clinical Decision Systems
AI-enabled diagnostics, decision support, data platforms, remote care, and digital medicine.
Pharma Strategy & Commercialisation
Market access, portfolio strategy, industry partnerships, reimbursement, and clinical adoption.
Biomaterials, Drug Delivery & Advanced Therapies
Novel delivery systems, regenerative platforms, cell therapies, and bioengineered solutions.
Healthcare Systems, Policy & Access
Clinical adoption, health economics, patient access, reimbursement, and system integration.
Industry–Academia Collaboration Models
Partnership models linking universities, hospitals, biotech firms, pharma, investors, and innovation ecosystems.
Programme at a glance
A professionally structured three-day scientific programme combining keynote lectures, oral presentations, a dedicated poster session, interdisciplinary exchange, networking, and collaboration.
Day 01
Opening, keynotes & scientific sessions
Opening ceremony, keynote lectures, parallel scientific presentations, poster interaction, and welcome networking.
Day 02
Keynotes, scientific sessions & posters
Keynote lectures and parallel scientific presentations followed by the dedicated poster session, author interaction, and collaboration networking.
Day 03
Final sessions & networking afternoon
Final parallel scientific sessions and closing remarks before lunch, followed by dedicated networking, meetings, and collaboration time.
How participation works
Choose the participation route that suits you. Authors may submit an abstract for oral or poster presentation, while delegates may register without presenting. Total participation is limited to 120 attendees.
Step 01
Choose participation
Participate as an oral presenter, poster presenter, delegate, industry representative, or partner.
Step 02
Submit & receive confirmation
Authors submit an abstract for review. Delegates may proceed directly to registration.
Step 03
Complete registration
Accepted presenters and delegates complete registration to secure one of the 120 places.
Need an invoice or participation support?
We can support invoices, participation confirmation, invitation documentation, and visa-letter guidance.
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Host location
Hilton Singapore Orchard • Orchard Road • Singapore
Venue & access
The congress will take place at Hilton Singapore Orchard, 333 Orchard Road, Singapore 238867. The hotel is located on Orchard Road, providing a central Singapore setting for international delegates, clinical and biotechnology professionals, researchers, and industry participants.
City
Singapore
Host venue
Hilton Singapore Orchard